Scientific and Ethical Issues in the Use of Placebo and Active Controls in Clinical Trials

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2003-06-01

• Fields of study

  Medicine, Philosophy

• Identifiers
  DOI 10.1359/jbmr.2003.18.6.1121PMID 12817767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo-controlled trials and the Declaration of Helsinki.

  2002cited by this paper
• The ethics of placebo-controlled trials--a middle ground.

  2001cited by this paper
• The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective

  2001cited by this paper
• Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.

  2001cited by this paper
• Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.

  2000cited by this paper
• Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues

  2000cited by this paper
• Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases

  2000cited by this paper
• Effects of medical interventions on suicidal behavior. Summary and conclusions.

  1999cited by this paper
• Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

  1999cited by this paper
• Science, ethics, and the future of research into maternal infant transmission of HIV-1. Perinatal HIV Intervention Research in Developing Countries Workshop participants.

  1999cited by this paper
• Alteplase not yet proven for acute ischaemic stroke.

  1998cited by this paper
• Education and debate

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Ethical complexities of conducting research in developing countries.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries.

  1997cited by this paper
• Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths

  1996cited by this paper
• Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory Myths

  1996cited by this paper
• Trials to assess equivalence: the importance of rigorous methods

  1996cited by this paper
• Comparing treatments

  1995cited by this paper
• The continuing unethical use of placebo controls.

  1994cited by this paper
• Council for International Organizations of Medical Sciences

  1991cited by this paper
• Treatment evaluation in active control studies.

  1987cited by this paper
• Placebos and controlled trials under attack

  1979cited by this paper

• Tramadol in the elderly : pharmacokinetic and pharmacodynamic modelling in healthy young and elderly subjects

  2018cites this paper
• Design considerations for clinical investigations of osteoporosis

  2013cites this paper
• The network meta-analytic-predictive approach to non-inferiority trials

  2013cites this paper
• Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.

  2008cites this paper
• CHAPTER 67 – Design Considerations for Clinical Investigations of Osteoporosis

  2008cites this paper
• Ethics of placebo-controlled clinical trials in multiple sclerosis

  2008cites this paper
• Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.

  2007cites this paper
• Evidence-based medicine and common sense: practical and ethical issues in clinical trials for osteoporosis

  2006cites this paper
• How useful are measures of BMD and bone turnover?*

  2005cites this paper
• Challenges and opportunities: what we are learning from the clinical natalizumab experience

  2005cites this paper
• Ethical Issues in MS Clinical Trials

  2005influential citation
• Ethical Issues in Clinical Research on Fracture Prevention in Patients With Osteoporosis

  2003cites this paper
• Ethical Issues in the Design of Osteoporosis Clinical Trials: The State of the Question

  2003cites this paper